Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 4;9(12):e114356.
doi: 10.1371/journal.pone.0114356. eCollection 2014.

Genotypic and phenotypic applications for the differentiation and species-level identification of achromobacter for clinical diagnoses

Affiliations

Genotypic and phenotypic applications for the differentiation and species-level identification of achromobacter for clinical diagnoses

Margarita Gomila et al. PLoS One. .

Abstract

The Achromobacter is a genus in the family Alcaligenaceae, comprising fifteen species isolated from different sources, including clinical samples. The ability to detect and correctly identify Achromobacter species, particularly A. xylosoxidans, and differentiate them from other phenotypically similar and genotypically related Gram-negative, aerobic, non-fermenting species is important for patients with cystic fibrosis (CF), as well as for nosocomial and other opportunistic infections. Traditional phenotypic profile-based analyses have been demonstrated to be inadequate for reliable identifications of isolates of Achromobacter species and genotypic-based assays, relying upon comparative 16S rRNA gene sequence analyses are not able to insure definitive identifications of Achromobacter species, due to the inherently conserved nature of the gene. The uses of alternative methodologies to enable high-resolution differentiation between the species in the genus are needed. A comparative multi-locus sequence analysis (MLSA) of four selected 'house-keeping' genes (atpD, gyrB, recA, and rpoB) assessed the individual gene sequences for their potential in developing a reliable, rapid and cost-effective diagnostic protocol for Achromobacter species identifications. The analysis of the type strains of the species of the genus and 46 strains of Achromobacter species showed congruence between the cluster analyses derived from the individual genes. The MLSA gene sequences exhibited different levels of resolution in delineating the validly published Achromobacter species and elucidated strains that represent new genotypes and probable new species of the genus. Our results also suggested that the recently described A. spritinus is a later heterotypic synonym of A. marplatensis. Strains were analyzed, using whole-cell Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight mass spectrometry (MALDI-TOF MS), as an alternative phenotypic profile-based method with the potential to support the identifications determined by the genotypic DNA sequence-based MLSA. The MALDI-TOF MS data showed good accordance in strain groupings and identifications by the MLSA data.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Phylogenetic tree of the strains of Achromobacter used in this study based on the phylogenetic analysis of recA gene.
Distance matrix was calculated by the Jukes-Cantor method. Dendrogram was generated by neighbor-joining. Bordetella pertussis CCUG 30873T was used as an outgroup. The bar indicates sequence divergence. Bootstrap values of more than 500 (from 1000 replicates) are indicated at the nodes.
Figure 2
Figure 2. Dendogram of relatedness between the Achromobacter species strains analyzed based on MALDI-TOF MS analysis.
Figure 3
Figure 3. The variation in recA and nrdA-765 sequences among Achromobacter species.
The y-axis shows the number of nucleotide positions, within 50-nucleotide position intervals (x-axis), in the respective sequences that exhibit variation between the type strains of the species of Achromobacter.

References

    1. LiPuma JJ (2010) The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 23:299–323. - PMC - PubMed
    1. Peleg AY, Hooper DC (2010) Hospital-acquired infections due to Gram-negative bacteria. N Engl J Med 362:1804–1813. - PMC - PubMed
    1. Amoureux L, Bador J, Fardeheb S, Mabille C, Couchot C, et al. (2013) Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates. Appl Environ Microbiol 79:7142–7149. - PMC - PubMed
    1. De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M (2007) Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros 6:75–78. - PubMed
    1. Barrado L, Brañas P, Orellana MA, Martínez MT, García G, et al. (2013) Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain. J Clin Microbiol 51:1927–1930. - PMC - PubMed

Publication types

LinkOut - more resources